臨床微生物学の世界市場レポート 2025年

臨床微生物学の市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は8.7％で、103億1,000万米ドルに成長します。予測期間の成長は、迅速な結果に対する需要、個別化治療の重視、サーベイランス需要の増加、ヘルスケア関連感染の重視、ポイントオブケア検査の統合などに起因します。予測期間の主な動向には、オミックス技術の統合、共同イノベーション、ヘルスケア関連感染への認識、規制の影響、技術の進歩などがあります。

感染症罹患率の上昇が臨床微生物学市場の成長を牽引すると予測されます。感染症は、細菌、真菌、寄生虫などの有害な微生物によって引き起こされる病気です。臨床微生物学は、患者の病気を管理・治療するために、これらの感染因子を分離し、特徴を明らかにする上で重要な役割を果たしています。例えば、2024年5月、スイスに本部を置く政府間機関である世界保健機関（WHO）は、2022年の世界におけるHIVの新規感染者数は130万人（範囲は10～170万人）であったと報告しました。これは、以前に報告された280万人の感染から54％の大幅な減少を意味します。このように、感染症の増加は臨床微生物学市場の拡大に寄与しています。

臨床微生物学市場は、臨床診断への公共投資と民間投資の増加によって成長します。両部門からの資金提供の増加は、診断ツール、検査能力、感染症への公衆衛生対応における進歩の触媒として機能します。英国政府が2023年2月の時点で医療機器承認への投資強化にコミットしていることは、この動向を示しています。MedTech newsが報じた2023年のヘルステック業界へのプライベート・エクイティ投資額1,118億米ドルは、臨床診断における資金調達全体の急増にさらに貢献し、臨床微生物学市場の成長を裏付けています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の臨床微生物学 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の臨床微生物学市場：成長率分析
• 世界の臨床微生物学市場の実績：規模と成長, 2019-2024
• 世界の臨床微生物学市場の予測：規模と成長, 2024-2029, 2034F
• 世界の臨床微生物学総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の臨床微生物学市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 実験器具
• 微生物分析装置
• 試薬
• 世界の臨床微生物学市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 呼吸器疾患
• 性感染症
• 尿路感染症
• 歯周病
• その他の疾患
• 世界の臨床微生物学市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断検査室
• その他のエンドユーザー
• 世界の臨床微生物学市場：実験器具のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• インキュベーター
• オートクレーブ
• 顕微鏡
• 培地調製装置
• 世界の臨床微生物学市場：微生物分析装置のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自動分析装置
• 質量分析装置
• PCR分析装置
• 世界の臨床微生物学市場：試薬のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 培養培地
• ステインと染料
• 抗体
• 診断キット

第7章 地域別・国別分析

• 世界の臨床微生物学市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の臨床微生物学市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 臨床微生物学市場：競合情勢
• 臨床微生物学市場：企業プロファイル
  • bioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• QIAGEN NV
• 3M
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Hologic Inc.
• Agilent Technologies Inc.
• Merck Group
• Shimadzu Corporation
• Neogen Corporation
• Vacutest Kima SRL
• Arrow Diagnostics SRL
• OpGen
• Becton Dickinson and Company
• Johnson & Johnson
• Sanofi SA

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 臨床微生物学市場2029：新たな機会を提供する国
• 臨床微生物学市場2029：新たな機会を提供するセグメント
• 臨床微生物学市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Clinical microbiology is a branch of medical science that encompasses a wide range of testing methodologies, methods for isolating and identifying various microorganisms, and the application of microbes in clinical settings to improve health.

The main products associated with clinical microbiology include laboratory instruments, microbiology analyzers, and reagents. Laboratory instruments are employed for various laboratory operations such as diagnostics, experiments, and analysis. These instruments, which include vessels and tools, are used in laboratory settings without altering the physical and chemical properties of the products involved in operations. Clinical microbiology plays a crucial role in detecting indications related to respiratory diseases, sexually transmitted diseases, urinary tract infections, periodontal diseases, and other health conditions. The products in this field find application in hospitals, diagnostic laboratories, and other end-users involved in healthcare and medical research.

The clinical microbiology market research report is one of a series of new reports from The Business Research Company that provides clinical microbiology market statistics, including clinical microbiology industry global market size, regional shares, competitors with a clinical microbiology market share, detailed clinical microbiology market segments, market trends and opportunities, and any further data you may need to thrive in the clinical microbiology industry. This clinical microbiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical microbiology market size has grown strongly in recent years. It will grow from $6.95 billion in 2024 to $7.4 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to rise of antimicrobial resistance, infectious disease outbreaks, globalization and travel, aging population, increased healthcare expenditure.

The clinical microbiology market size is expected to see strong growth in the next few years. It will grow to $10.31 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to demand for rapid results, focus on personalized treatments, increasing demand for surveillance, emphasis on healthcare-associated infections, integration of point-of-care testing. Major trends in the forecast period include omics technology integration, collaborative innovation, healthcare-associated infections awareness, regulatory influence, technological advancements.

The rising incidence of infectious diseases is anticipated to drive growth in the clinical microbiology market. Infectious diseases are illnesses caused by harmful microorganisms, including bacteria, fungi, and parasites. Clinical microbiology plays a crucial role in isolating and characterizing these infectious agents to manage and treat diseases in patients. For example, in May 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that there were 1.3 million (with a range of 1.0 to 1.7 million) new HIV infections worldwide in 2022. This marks a significant 54% reduction from the 2.8 million infections reported in previous years. Thus, the increasing prevalence of infectious diseases is contributing to the expansion of the clinical microbiology market.

The clinical microbiology market is set for growth propelled by the augmented public and private investments in clinical diagnostics. Increased funding from both sectors acts as a catalyst for advancements in diagnostic tools, laboratory capabilities, and public health responses to infectious diseases. The UK government's commitment to enhanced investment in medical device approval, as of February 2023, is indicative of this trend. Private equity investments of $111.8 billion in the healthTech industry in 2023, as reported by MedTech news, further contribute to the overall funding surge in clinical diagnostics, substantiating the growth of the clinical microbiology market.

Leading companies in the clinical microbiology market are increasingly allocating resources toward innovative diagnostic technologies and automation systems, including advanced laboratory automation solutions and next-generation sequencing, to boost pathogen detection efficiency and enhance patient care outcomes. One notable example is the new third-generation BD Kiestra Total Lab Automation System, an advanced robotic track system tailored for microbiology laboratories. This system allows for customizable automation configurations that streamline specimen processing, from inoculation to pathogen detection. For instance, in January 2023, Becton, Dickinson and Company, a U.S.-based medical device firm, introduced the third-generation BD Kiestra Total Lab Automation System specifically for microbiology laboratories. This robotic track system is compatible with the BD Kiestra microbiology laboratory solution, which automates lab specimen processing. Designed to address the evolving needs of laboratories, this new robotic track system facilitates the creation of a custom and flexible total lab automation setup that can connect multiple BD Kiestra modules.

Product innovations take center stage in the clinical microbiology market, with major companies focusing on developing new solutions to enhance patient care. Middleware systems like MAESTRIA are designed to revolutionize workflow management within clinical microbiology laboratories. Launched by bioMerieux in January 2023, MAESTRIA offers features such as workflow management, biological expertise, and data management, streamlining laboratory processes and optimizing surveillance reporting. The middleware is compatible with existing instruments and workflows, providing an integrated solution for microbiology laboratory processes.

Strategic acquisitions play a vital role in shaping the clinical microbiology market landscape. In April 2022, DCN Dx, a US-based company specializing in rapid point-of-care tests, acquired Biomed Diagnostics Inc. This acquisition aims to bolster DCN Diagnostics' product portfolio and market presence in microbial testing within the clinical microbiology domain. Biomed Diagnostics, a US-based manufacturer known for high-quality microbiology devices, adds valuable capabilities to DCN Dx, positioning them for growth in the clinical microbiology market.

Major companies operating in the clinical microbiology market are bioMerieux SA, Danaher Corporation, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Corporation, QIAGEN NV, 3M, Bio-Rad Laboratories Inc., Bruker Corporation, Hologic Inc., Agilent Technologies Inc., Merck Group, Shimadzu Corporation, Neogen Corporation, Vacutest Kima SRL, Arrow Diagnostics SRL, OpGen, Becton Dickinson and Company, Johnson & Johnson, Sanofi SA, Illumina Inc., Medtronic, Cepheid Inc., Quidel Corporation, Luminex Corporation, DiaSorin S.p.A., GenMark Diagnostics Inc., T2 Biosystems Inc., Nanosphere Health Sciences Inc.

North America was the largest region in the clinical microbiology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical microbiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clinical microbiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical microbiology market consists of sales of incubators, gram strainers, bacterial colony counters, autoclave sterilizers, microbial air samplers, and anaerobic culture systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Microbiology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical microbiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clinical microbiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical microbiology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Laboratory Instruments; Microbiology Analyzers; Reagents
• 2) By Indication: Respiratory Diseases; Sexually Transmitted Diseases; Urinary Tract infections; Periodontal Diseases; Other Diseases
• 3) By End-user: Hospitals; Diagnostic Laboratories; Other End-user
• Subsegments:
• 1) By Laboratory Instruments: Incubators; Autoclaves; Microscopes; Culture Media Preparation Equipment
• 2) By Microbiology Analyzers: Automated Analyzers; Mass Spectrometry Analyzers; PCR Analyzers
• 3) By Reagents: Culture Media; Stains And Dyes; Antibodies; Diagnostic Kits
• Companies Mentioned: bioMerieux SA; Danaher Corporation; Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Clinical Microbiology Market Characteristics

3. Clinical Microbiology Market Trends And Strategies

4. Clinical Microbiology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Clinical Microbiology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Clinical Microbiology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Clinical Microbiology Market Growth Rate Analysis
• 5.4. Global Clinical Microbiology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Clinical Microbiology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Clinical Microbiology Total Addressable Market (TAM)

6. Clinical Microbiology Market Segmentation

• 6.1. Global Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Instruments
• Microbiology Analyzers
• Reagents
• 6.2. Global Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Respiratory Diseases
• Sexually Transmitted Diseases
• Urinary Tract infections
• Periodontal Diseases
• Other Diseases
• 6.3. Global Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Other End-user
• 6.4. Global Clinical Microbiology Market, Sub-Segmentation Of Laboratory Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Incubators
• Autoclaves
• Microscopes
• Culture Media Preparation Equipment
• 6.5. Global Clinical Microbiology Market, Sub-Segmentation Of Microbiology Analyzers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automated Analyzers
• Mass Spectrometry Analyzers
• PCR Analyzers
• 6.6. Global Clinical Microbiology Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Culture Media
• Stains And Dyes
• Antibodies
• Diagnostic Kits

7. Clinical Microbiology Market Regional And Country Analysis

• 7.1. Global Clinical Microbiology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Clinical Microbiology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Clinical Microbiology Market

• 8.1. Asia-Pacific Clinical Microbiology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Clinical Microbiology Market

• 9.1. China Clinical Microbiology Market Overview
• 9.2. China Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Clinical Microbiology Market

• 10.1. India Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Clinical Microbiology Market

• 11.1. Japan Clinical Microbiology Market Overview
• 11.2. Japan Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Clinical Microbiology Market

• 12.1. Australia Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Clinical Microbiology Market

• 13.1. Indonesia Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Clinical Microbiology Market

• 14.1. South Korea Clinical Microbiology Market Overview
• 14.2. South Korea Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Clinical Microbiology Market

• 15.1. Western Europe Clinical Microbiology Market Overview
• 15.2. Western Europe Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Clinical Microbiology Market

• 16.1. UK Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Clinical Microbiology Market

• 17.1. Germany Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Clinical Microbiology Market

• 18.1. France Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Clinical Microbiology Market

• 19.1. Italy Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Clinical Microbiology Market

• 20.1. Spain Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Clinical Microbiology Market

• 21.1. Eastern Europe Clinical Microbiology Market Overview
• 21.2. Eastern Europe Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Clinical Microbiology Market

• 22.1. Russia Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Clinical Microbiology Market

• 23.1. North America Clinical Microbiology Market Overview
• 23.2. North America Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Clinical Microbiology Market

• 24.1. USA Clinical Microbiology Market Overview
• 24.2. USA Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Clinical Microbiology Market

• 25.1. Canada Clinical Microbiology Market Overview
• 25.2. Canada Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Clinical Microbiology Market

• 26.1. South America Clinical Microbiology Market Overview
• 26.2. South America Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Clinical Microbiology Market

• 27.1. Brazil Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Clinical Microbiology Market

• 28.1. Middle East Clinical Microbiology Market Overview
• 28.2. Middle East Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Clinical Microbiology Market

• 29.1. Africa Clinical Microbiology Market Overview
• 29.2. Africa Clinical Microbiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Clinical Microbiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Clinical Microbiology Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Clinical Microbiology Market Competitive Landscape And Company Profiles

• 30.1. Clinical Microbiology Market Competitive Landscape
• 30.2. Clinical Microbiology Market Company Profiles
  • 30.2.1. bioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Thermo Fisher Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Clinical Microbiology Market Other Major And Innovative Companies

• 31.1. QIAGEN NV
• 31.2. 3M
• 31.3. Bio-Rad Laboratories Inc.
• 31.4. Bruker Corporation
• 31.5. Hologic Inc.
• 31.6. Agilent Technologies Inc.
• 31.7. Merck Group
• 31.8. Shimadzu Corporation
• 31.9. Neogen Corporation
• 31.10. Vacutest Kima SRL
• 31.11. Arrow Diagnostics SRL
• 31.12. OpGen
• 31.13. Becton Dickinson and Company
• 31.14. Johnson & Johnson
• 31.15. Sanofi SA

32. Global Clinical Microbiology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Clinical Microbiology Market

34. Recent Developments In The Clinical Microbiology Market

35. Clinical Microbiology Market High Potential Countries, Segments and Strategies

• 35.1 Clinical Microbiology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Clinical Microbiology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Clinical Microbiology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer